High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases

Vaccine

Volumn 26, Issue 29-30, 2008, Pages 3778-3782

  Smith, Kristen A ^a   Colvin, Christopher J ^a   Weber, Patty S D ^a   Spatz, Stephen J ^b   Coussens, Paul M ^a  

^a Department of Animal Science   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Influenza; PBS 1; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; AVIAN INFLUENZA; CELL ISOLATION; CELL STRAIN; CHICK EMBRYO; CONTROLLED STUDY; DRUG EFFECT; EMBRYO CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; VIROGENESIS; VIRUS IDENTIFICATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; DOGS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; PEPTIDE HYDROLASES; TISSUE CULTURE TECHNIQUES; VIRUS CULTIVATION;

EID: 45049084091     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.048     Document Type: Article

References (22)

1. Wood J.M., Major D., Newman R.W., Dunleavy U., Nicolson C., Robertson J.S., et al. Preparation of vaccines against H5N1 influenza. Vaccine 20 Suppl. 2 (2002) S84-S87
2. Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP); 2006.
3. James J.M., Zeiger R.S., Lester M.R., Fasano M.B., Gern J.E., Mansfield L.E., et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 133 5 (1998) 624-628
4. Poland G.A., Jacobson R.M., and Targonski P.V. Avian and pandemic influenza: an overview. Vaccine 25 16 (2007) 3057-3061
5. Patriarca P.A. Use of cell lines for the production of influenza virus vaccines: an appraisal of technical, manufacturing, and regulatory considerations (2007), World Health Organization, Geneva [April 10, 2007]
6. Katz J.M., and Webster R.G. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. J Gen Virol 73 Pt 5 (1992) 1159-1165
7. Lavrentieva I.N., Medvedeva T.E., and Golubev D.B. Characterization of the reproduction of influenza A epidemic viruses in cell cultures. Acta Virol 30 2 (1986) 137-142
8. Govorkova E.A., Kodihalli S., Alymova I.V., Fanget B., and Webster R.G. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev Biol Standard 98 (1999) 39-51 [discussion 73-4]
9. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., and Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 19 17-19 (2001) 2716-2721
10. Ogura H., and Fujiwara T. Establishment and characterization of a virus-free chick cell line. Acta Med Okayama 41 3 (1987) 141-143
11. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 27 3 (1937) 493-497
12. Nobusawa E., Ishihara H., Morishita T., Sato K., and Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 278 2 (2000) 587-596
13. Thompson C.I., Barclay W.S., and Zambon M.C. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. J Antimicrob Chemother 53 5 (2004) 759-765
14. Masurel N., Ophof P., and de Jong P. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J Hyg 87 2 (1981) 201-209
15. Rimmelzwaan G.F., Baars M., Claas E.C., and Osterhaus A.D. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 74 1 (1998) 57-66
16. Tobita K., Sugiura A., Enomote C., and Furuyama M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol 162 1 (1975) 9-14
17. Govorkova E.A., Kaverin N.V., Gubareva L.V., Meignier B., and Webster R.G. Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J Infect Dis 172 1 (1995) 250-253
18. Govorkova E.A., Murti G., Meignier B., de Taisne C., and Webster R.G. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol 70 8 (1996) 5519-5524
19. Nakamura K., and Homma M. Protein synthesis in Vero cells abortively infected with influenza B virus. J Gen Virol 56 Pt 1 (1981) 199-202
20. Valette M., Allard J.P., Aymard M., and Millet V. Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990. Antimicrob Agents Chemother 37 10 (1993) 2239-2240
21. Kaverin N.V., and Webster R.G. Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J Virol 69 4 (1995) 2700-2703
22. Reina J., Fernandez-Baca V., Blanco I., and Munar M. Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture. J Clin Microbiol 35 7 (1997) 1900-1901